I thought that some may find the study below interesting. It addresses concerns that some have asked about in the past. It is also fairly recent, 2008, and makes the following statements.
" Unlike pharmaceutical antibiotics, which destroy beneficial enzymes, colloidal silver leaves these beneficial enzymes intact (Hall et al., 1999). An added advantage to the use of silver is that it has variously been shown to have high safety profile in vivo and cannot interact or interfere with other medicines being taken (Iroha et al., 2007). Furthermore, it is known not to destroy the normal microbial flora of the gut thereby avoiding the negative effects of traditional antibiotics that kill good bacteria in the lower digestive tract (Beaker and Spadaro, 1981)." More below. - Steve N http://www.academicjournals.org/sre/PDF/pdf2008/May/Iroha%20et%20al%20.p df In vitro evaluation of the activity of colloidal silver concentrate against Pseudomonas aeruginosa isolated from postoperative wound infection "RESULTS AND DISCUSSION The result of sensitivity studies (Table 1) shows that P. aeruginosa was susceptible to antimicrobial action of colloidal silver concentrate. The MIC results (Table 2) of colloidal silver reveals that the test organisms were susceptible within the ranges of 0.078 to 0.313 ug/ml. The killing rate studies showed that the population of P. aeruginosa was drastically reduced to non- existing level at the 90th min (Figure 1). The first order killing rate constant was estimated to be 0.084 min-1. This demonstrates that colloidal silver has an antibacterial activity against P. aeruginosa. The rate at which microorganism develops resistance to conventional antimicrobial agents posses a serious public health problem globally. P. aeruginosa is known to be resistant to many antimicrobial agents and has been implicated in post operative wound infections (Oguntibeju and Nwobu, 2004). Faced with the challenge of increasing incidence of infections caused by P. aeruginosa and its resistance problem, an attempt was made to establish the in vitro antibacterial activity of colloidal silver concentrate in our environment. Colloidal silver is one agent that has a tremendous antimicrobial effect and has been used successfully in the treatment of many infectious diseases without visible side effect (Wickless and Schwader, 2004). Our study has further confirmed the potent antibacterial activity of colloidal silver concentrate against P. aeruginosa. This presents a clear indication for the potential applicability of colloidal silver in the treatment of some post operative wound infections caused by this organism. Presently, the use of colloidal silver in the treatment of various infectious diseases is growing exponentially. It has been shown that its presence near a virus, fungi, bacteria or any other single cell pathogen disables its oxygen metabolizing enzymes, and within a few minutes the pathogen suffocates, dies and is cleared out of the body by the immune lymphatic and elimination system (Hall et al., 1999). Unlike pharmaceutical antibiotics, which destroy beneficial enzymes, colloidal silver leaves these beneficial enzymes intact (Hall et al., 1999). An added advantage to the use of silver is that it has variously been shown to have high safety profile in vivo and cannot interact or interfere with other medicines being taken (Iroha et al., 2007). Furthermore, it is known not to destroy the normal microbial flora of the gut thereby avoiding the negative effects of traditional antibiotics that kill good bacteria in the lower digestive tract (Beaker and Spadaro, 1981). The result from Figure 1 showed that the killing potency of colloidal silver is very high, killing a given population of P. aeruginosa within 90 min. This could be attributed to its small particle size that increases its surface area, which enables it to penetrate the organism's cell membrane. Also, the ionic (positive charge) nature is considered the primary benefiting feature of colloidal silver being able to aggressively attach to microbial cells and kill them (Hall et al., 1999). In the present study, colloidal silver was shown to demonstrate very potent antibacterial activity against P. aeruginosa isolated from post operative eye infection. This activity should be urgently explo- red in the development of highly active antibacterial therapeutic agents to combat the rapidly increasing infectious diseases that currently challenge the present arsenal of antibacterial drugs." -- The Silver List is a moderated forum for discussing Colloidal Silver. Rules and Instructions: http://www.silverlist.org Unsubscribe: <mailto:[email protected]?subject=unsubscribe> Archives: http://www.mail-archive.com/[email protected]/maillist.html Off-Topic discussions: <mailto:[email protected]> List Owner: Mike Devour <mailto:[email protected]>

